Effectiveness of Convalescent Plasma Therapy in Severe or Critically Ill COVID-19 Patients: A Retrospective Cohort Study

PURPOSE: Coronavirus disease-2019 (COVID-19) is a novel respiratory infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); there are few specific treatments. Convalescent plasma (CP), donated by people who have recovered from COVID-19, is an investigational therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, YunSuk, Sohn, YuJin, Hyun, JongHoon, Baek, YaeJee, Kim, MooHyun, Kim, JungHo, Ahn, JinYoung, Jeong, SuJin, Ku, NamSu, Yeom, Joon-Sup, Ahn, MiYoung, Oh, DongHyun, Choi, JaePhil, Kim, SinYoung, Lee, KyoungHwa, Song, YoungGoo, Choi, JunYong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382726/
https://www.ncbi.nlm.nih.gov/pubmed/34427065
http://dx.doi.org/10.3349/ymj.2021.62.9.799

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382726/
https://www.ncbi.nlm.nih.gov/pubmed/34427065
http://dx.doi.org/10.3349/ymj.2021.62.9.799

Ejemplares similares